Showing results (131-140 of 184) with videos related to
Sort By:
Pageof 19
The British Journal of Ophthalmology|January 19, 2024
Deep learning model for extensive smartphone-based diagnosis and triage of cataracts and multiple corneal diseasesYuta Ueno, Masahiro Oda, Takefumi Yamaguchi, et al.Ophthalmology. Retina|October 14, 2019
Efficacy of Photodynamic Therapy for Polypoidal Choroidal Vasculopathy Associated with and without Pachychoroid PhenotypesMasayuki Hata, Miho Tagawa, Akio Oishi, et al.American Journal of Ophthalmology|January 31, 2015
One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcomeAkio Oishi, Akitaka Tsujikawa, Kenji Yamashiro, et al.Scientific Reports|April 12, 2020
Usefulness of Denoising Process to Depict Myopic Choroidal Neovascularisation Using a Single Optical Coherence Tomography Angiography ImageYuka Sawai, Manabu Miyata, Akihito Uji, et al.American Journal of Ophthalmology|November 7, 2012
Three-dimensional tomographic features of dome-shaped macula by swept-source optical coherence tomographyAbdallah A Ellabban, Akitaka Tsujikawa, Akiko Matsumoto, et al.Journal of Hypertension|October 31, 2017
Association of retinal vessel calibers and longitudinal changes in arterial stiffness: the Nagahama studyKyoko Kawashima-Kumagai, Yasuharu Tabara, Kenji Yamashiro, et al.Retina (Philadelphia, Pa.)|June 20, 2023
TEN-YEAR VISUAL OUTCOME AND CHANGE IN CHORIORETINAL ATROPHY AFTER INTRAVITREAL RANIBIZUMAB FOR MACULAR NEOVASCULARIZATION IN PATHOLOGIC MYOPIARyo Sakata, Manabu Miyata, Sotaro Ooto, et al.Ophthalmology|May 1, 2022
Genome-wide Survival Analysis for Macular Neovascularization Development in Central Serous Chorioretinopathy Revealed Shared Genetic Susceptibility with Polypoidal Choroidal VasculopathyYuki Mori, Masahiro Miyake, Yoshikatsu Hosoda, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2024
Genome-Wide Association Analysis Identifies LILRB2 Gene for Pathological MyopiaLingxi Jiang, Lulin Huang, Chao Dai, et al.BMJ Open|April 21, 2026
Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trialMasahiro Miyake, Ayako Takahashi, Takayuki Baba, et al.Pageof 19